Advertisement

Document › Details
Agilent Technologies Inc.. (3/30/20). "Press Release: Agilent Announces New Class 1 Triple Quadrupole LC/MS System. Purpose-built and Validated for Clinical Laboratories". Santa Clara, CA.
Agilent Technologies Inc. (NYSE: A) today introduced the Agilent K6460S Clinical Edition TQ LC/MS system, designed to improve in vitro diagnostic workflows in clinical labs.
Agilent’s next-generation clinical edition triple quadrupole LC/MS system, the K6460S, is listed as a Class I medical device with the U.S. Food and Drug Administration. The system includes a preconfigured liquid chromatograph and mass spectrometer, as well as the clinical edition of Agilent MassHunter software, which provides an easy-to-use and intuitive submission-to-reporting workflow.
When performing diagnostic assays, the K6460S provides the specificity and selectivity that clinical labs require, delivering robust results with more accuracy, and increasing the reliability of target compound detection in complex matrices.
“We are pleased to announce the launch of the K6460S, our newly validated LC/MS system in the United States,” said Monty Benefiel, vice president and general manager of Agilent's Mass Spectrometry Division. “Agilent has a strong reputation in providing reliable and routine solutions to clinical laboratories. We believe that the strength and robustness of our technologies, combined with our depth of expertise in our services and support offerings, makes Agilent a powerful partner for clinical diagnostic labs.”
“Using TQ LC/MS increases the specificity, selectivity, and accuracy of many clinical diagnostic assays compared to traditional binding assays,” said Ken Lewis, chief executive officer of OpAns, LLC. “The fully validated Agilent K6460S is a robust and reliable platform that boosts productivity via technology purpose-built for diagnostic workflows.”
It was also announced in January 2020 that the Agilent LC-MS/MS had been approved by China's national drug administration (NMPA) for use in the China domestic clinical diagnosis market.
Agilent is a leader in providing IVD medical devices to improve the quality of health care globally and has driven investment in this key area to develop and launch robust, reliable LC-MS/MS IVD systems. These instruments improve and simplify the analysis of samples and address specific workflows to expedite the efficacy of clinical diagnostics.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets. Now in its 20th year as an independent company delivering insight and innovation toward improving the quality of life, Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. The company generated revenue of $5.16 billion in fiscal 2019 and employs 16,300 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and Facebook.
Record changed: 2023-06-05 |
Advertisement

More documents for Agilent (Group)
- [1] Agilent Technologies Inc.. (9/5/23). "Press Release: Agilent Names Philip Binns to Lead Life Sciences and Applied Markets Group". Santa Clara, CA....
- [2] Illumina, Inc.. (9/5/23). "Press Release: Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer". San Diego, CA....
- [3] Agilent Technologies Inc.. (9/4/23). "Press Release: Agilent and ACTRIS Partner to Accelerate Cell and Gene Therapy in Singapore". Singapore....
- [4] Agilent Technologies Inc.. (6/12/23). "Press Release: Agilent Introduces New Comprehensive GPC/SEC Solutions at HPLC 2023 Conference". Santa Clara, CA....
- [5] Synthego Corporation. (5/17/23). "Press Release: Synthego Announces Invalidation of Agilent Patents in CRISPR Dispute". Redwood City, CA....
- [6] Agilent Technologies Inc.. (4/12/23). "Press Release: Agilent and PathAI Partner to Deliver AI-Powered Assay Development Solutions for Biopharma Research and Clinical Applications". Santa Clara, CA....
- [7] Agilent Technologies Inc.. (3/22/23). "Press Release: Agilent Honored with Asia Pacific Bioprocessing Excellence Award 2023 for Analytical Services". Singapore....
- [8] Agilent Technologies Inc.. (3/10/23). "Press Release: Agilent Announces Digital Pathology Scanner Distribution Agreement with Hamamatsu". Santa Clara, CA....
- [9] Agilent Technologies Inc.. (3/9/23). "Press Release: Agilent Announces Acquisition of e-MSion, Early-Stage Company Behind ECD Technology that Helps Accelerate Drug Development". Santa Clara, CA....
- [10] Agilent Technologies Inc.. (3/8/23). "Press Release: Agilent Announces Global Distribution Agreement with Proscia to Accelerate Data-Driven Precision Medicine". Santa Clara, CA....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement

» top